Rekvina Labs Ltd

BSE : 526075

NSE :

Sector :Health care

ISIN Code : INE092O01028

NSE

Not Listed

BSE

4.50
0.00 (0.00%)

12:00 AM,13th Dec 2021

Open

4.50

High

4.50

Low

4.50

Board Meeting Outcome for Board Meeting Held On 14Th November 2024

12:00 AM,13th Dec 2021

Pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule III of SEBI (LODR)Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meetingheld today i.e. 14th November 2024 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September 2024. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September 2024.